Why is Tatva Chintan falling/rising?

As of 18-Jul, Tatva Chintan Pharma Chem Ltd is experiencing a price increase, currently at 1,000.10, which reflects a rise of 57.3 or 6.08%. The stock opened with a gain of 2.89% today and reached an intraday high of Rs 1062.7, marking a 12.72% increase. Over the past week, the stock has outperformed the sector by 7.11% and has shown positive returns of 5.48% over the last week and 7.08% over the past month. However, it is important to note that the stock has seen a significant decline of 10.51% over the past year and a drastic drop of 58.74% over the last three years. The company maintains a low Debt to Equity ratio, which is a positive factor that may contribute to investor confidence despite the recent volatility.
In the broader market context, the Sensex has shown a decline of 0.90% over the past week and a modest increase of 0.38% over the past month, indicating that Tatva Chintan's short-term performance is significantly better than the benchmark. The stock's year-to-date return of 13.29% also surpasses the Sensex's 4.63% increase, suggesting that investor sentiment towards Tatva Chintan is relatively strong compared to the overall market. However, a concerning aspect is the falling investor participation, with a delivery volume decrease of 39.98% against the 5-day average, which could indicate a potential risk if this trend continues.